v3.25.0.1
STOCKHOLDERS’ DEFICIT (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
SCHEDULE OF ASSUMPTIONS USED TO CALCULATE FAIR VALUE OF WARRANTS

 

  

September 30,

2024

   December 31, 2023 
   Unmodified
Warrants		   Modified
Warrants		     
Dividend yield   —%   —%   —%
Volatility   114.2%   104.0%   105.1%
Risk-free interest rate   3.56%   3.55%   3.93%
Expected lives (years)   2.89    4.33    3.64 
Weighted average fair value  $0.165   $0.393   $2.064 

 

   December 31, 2023   December 31, 2022 
Dividend yield   -%   -%
Volatility   105.1%   96.8%
Risk-free interest rate   3.93%   3.99%
Expected lives (years)   3.64    4.64 
Weighted average fair value  $2.064   $2.850 
SCHEDULE OF WARRANTS OUTSTANDING

The following table is a summary of the Company’s warrants outstanding and exercisable as of September 30, 2024.

 

          Exercise Price   Number of Warrants Outstanding and Common Stock Underlying Warrants 
    Issuance Date  Expiration Date  per Share   September 30, 2024   December 31, 2023 
Unmodified August 2022 Warrants(1)   August 25, 2022  August 25, 2027  $13.20    433,321    799,985 
Modified August 2022 Warrants(1)   August 25, 2022  August 25, 2027  $4.13    55,553    - 
January 2024 Purchase Warrants(2)   January 26, 2024  July 26, 2029  $4.13    171,000    - 
July 2024 Purchase Warrants(2)   July 9, 2024  July 9, 2027  $2.25    1,248,527    - 
August 2024 Purchase Warrants(2)   August 1, 2024  August 1, 2029  $1.36    2,566,667    - 
                4,475,068    799,985 

Warrants outstanding as of December 31, 2023 and 2022 were as follows:

 

      Exercise Price   Number of Shares Outstanding under Warrant 
Issuance Date  Expiration Date  per Share   December 31, 2023   December 31, 2022 
August 25, 2022  August 25, 2027  $13.20    799,985    799,985 
            799,985    799,985 
SUMMARY OF STOCK OPTION ACTIVITY

The following table summarizes stock option activity for the 2010 Plan during the nine months ended September 30, 2024.

 

 

      
Options outstanding at December 31, 2023   245,154 
Options forfeited or expired   (199,794)
Options outstanding at September 30, 2024   45,360 

The activity related to shares available for grant under the 2010 Plan and the 2019 Plan for the years ended December 31, 2023 and 2022 was as follows:

 

   2010 Stock Option Plan   2019 Stock Option Plan   Total 
Shares available at December 31, 2021   -    248,613    248,613 
Shares added to the plan   -    -    - 
Options forfeited   2,650    198,625    201,275 
Options granted   -    (174,175)   (174,175)
Restricted stock units forfeited   -    346    346 
Restricted stock units granted   -    (29,223)   (29,223)
Shares expired   (2,650)   (5,754)   (8,404)
Shares available at December 31, 2022   -    238,432    238,432 
Shares added to the plan   -    333,333    333,333 
Options forfeited   41,950    250,859    292,809 
Options granted   -    (397,503)   (397,503)
Restricted stock units forfeited   -    -    - 
Restricted stock units granted   -    (259,161)   (259,161)
Shares expired   (41,950)   (99)   (42,049)
Shares available at December 31, 2023   -    165,861    165,861 
SUMMARY OF RSU ACTIVITY

The following table summarizes RSU activity for the 2019 Plan during the nine months ended September 30, 2024.

 

 

      
RSUs outstanding at December 31, 2023   59,463 
RSUs granted   273,951 
RSUs vested and issued   (149,387)
RSUs forfeited or expired   (30,277)
RSUs vested and unissued at September 30, 2024   153,750 
  
SCHEDULE OF ALLOCATION OF NON-CASH STOCK BASED COMPENSATION EXPENSE BY FUNCTIONAL AREA

 

                 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
(in thousands)  2024   2023   2024   2023 
Cost of revenue  $6   $7   $32   $26 
Research and development  $46   $65    136   $224 
Sales and marketing  $95   $(105)   139   $19 
General and administrative  $232   $451    556   $1,033 
Total  $379   $418   $863   $1,302 

The non-cash stock-based compensation expense included in cost of revenue and operating expenses by functional area for the years ended December 31, 2023 and 2022 was as follows:

 

   Year Ended 
   December 31, 
(in thousands)  2023   2022 
Cost of revenue  $33   $76 
Research and development   325    177 
Sales and marketing   47    354 
General and administrative   1,319    1,807 
Total  $1,724   $2,414 
Stock Incentive Plan 2019 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
SUMMARY OF STOCK OPTION ACTIVITY

The following table summarizes stock option activity for the 2019 Plan during the nine months ended September 30, 2024.

 

      
Options outstanding at December 31, 2023   514,768 
Options granted   514,974 
Options forfeited or expired   (235,652)
Options outstanding at September 30, 2024   794,090